New York State Teachers Retirement System Grows Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

New York State Teachers Retirement System raised its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 16.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,428 shares of the company’s stock after acquiring an additional 775 shares during the quarter. New York State Teachers Retirement System’s holdings in Phibro Animal Health were worth $114,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of PAHC. Geode Capital Management LLC boosted its holdings in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after purchasing an additional 27,201 shares during the period. Barclays PLC increased its stake in Phibro Animal Health by 25.7% during the 3rd quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after buying an additional 29,271 shares during the period. Algert Global LLC lifted its position in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares during the period. FMR LLC boosted its stake in Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after buying an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after purchasing an additional 729 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Stock Down 1.7 %

NASDAQ PAHC opened at $22.12 on Tuesday. The firm has a 50-day simple moving average of $22.20 and a 200 day simple moving average of $22.21. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The stock has a market cap of $895.93 million, a PE ratio of 46.08, a PEG ratio of 0.45 and a beta of 0.52. Phibro Animal Health Co. has a twelve month low of $11.98 and a twelve month high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, research analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.17%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 100.00%.

Wall Street Analysts Forecast Growth

PAHC has been the topic of a number of recent analyst reports. StockNews.com lowered Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Morgan Stanley raised their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Barclays boosted their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a report on Monday, February 10th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, Phibro Animal Health presently has a consensus rating of “Hold” and a consensus target price of $21.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.